EA031906B1 - Твердая пероральная лекарственная форма миртазапина и тизанидина для лечения болевого расстройства - Google Patents
Твердая пероральная лекарственная форма миртазапина и тизанидина для лечения болевого расстройства Download PDFInfo
- Publication number
- EA031906B1 EA031906B1 EA201591603A EA201591603A EA031906B1 EA 031906 B1 EA031906 B1 EA 031906B1 EA 201591603 A EA201591603 A EA 201591603A EA 201591603 A EA201591603 A EA 201591603A EA 031906 B1 EA031906 B1 EA 031906B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pain
- mirtazapine
- tizanidine
- dosage form
- solid oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013112747/15A RU2509560C1 (ru) | 2013-03-22 | 2013-03-22 | Новые терапевтические комбинации миртазапина для применения при болевых расстройствах |
PCT/RU2014/000165 WO2014148951A1 (ru) | 2013-03-22 | 2014-03-17 | Новые терапевтические комбинации миртазапина для применения при болевых расстройствах |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201591603A1 EA201591603A1 (ru) | 2016-01-29 |
EA031906B1 true EA031906B1 (ru) | 2019-03-29 |
Family
ID=50279596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591603A EA031906B1 (ru) | 2013-03-22 | 2014-03-17 | Твердая пероральная лекарственная форма миртазапина и тизанидина для лечения болевого расстройства |
Country Status (7)
Country | Link |
---|---|
CN (1) | CN105209044B (zh) |
EA (1) | EA031906B1 (zh) |
HK (1) | HK1214156A1 (zh) |
MY (1) | MY180772A (zh) |
RU (1) | RU2509560C1 (zh) |
UA (1) | UA112726C2 (zh) |
WO (1) | WO2014148951A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10322116B2 (en) * | 2014-01-21 | 2019-06-18 | Wockhardt Limited | Pharmaceutical compositions comprising antibacterial agents |
CN106243096B (zh) * | 2016-07-29 | 2019-11-29 | 上海璃道医药科技有限公司 | 三环类药物的新用途 |
UA126916C2 (uk) * | 2017-04-27 | 2023-02-22 | Др. Редді'З Лабораторіз Лімітед | Фармацевтична композиція кеторолаку |
RU2736713C1 (ru) * | 2019-12-02 | 2020-11-19 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Комбинация миртазапина и тизанидина для применения при болевых расстройствах |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080020076A1 (en) * | 2006-07-21 | 2008-01-24 | Khem Jhamandas | Methods and Therapies for Potentiating a Therapeutic Action of an Alpha-2 Adrenergic Receptor Agonist and Inhibiting and/or Reversing Tolerance to Alpha-2 Adrenergic Receptor Agonists |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL123716A (en) * | 1997-03-27 | 2001-03-19 | Akzo Nobel Nv | Therapeutic combinations of mirtazapine and an antipsychotic agent |
-
2013
- 2013-03-22 RU RU2013112747/15A patent/RU2509560C1/ru active
-
2014
- 2014-03-17 MY MYPI2015703040A patent/MY180772A/en unknown
- 2014-03-17 UA UAA201509384A patent/UA112726C2/uk unknown
- 2014-03-17 WO PCT/RU2014/000165 patent/WO2014148951A1/ru active Application Filing
- 2014-03-17 EA EA201591603A patent/EA031906B1/ru unknown
- 2014-03-17 CN CN201480017352.6A patent/CN105209044B/zh active Active
-
2016
- 2016-02-25 HK HK16102203.1A patent/HK1214156A1/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080020076A1 (en) * | 2006-07-21 | 2008-01-24 | Khem Jhamandas | Methods and Therapies for Potentiating a Therapeutic Action of an Alpha-2 Adrenergic Receptor Agonist and Inhibiting and/or Reversing Tolerance to Alpha-2 Adrenergic Receptor Agonists |
Non-Patent Citations (2)
Title |
---|
KALIKSTA® (Calixta). Instruktsia po primeneniju, protivopokazania i sostav. Entsiklopedia RLS® № LP-001110 dated 03.11.2011 [on-line], [retrieved on 18.06.2014]. Found in Internet: <URL: http://www.rlsnet.ra/tn_index_id_50150.htm>, p. 1-3 * |
SIRDALUD® (Sirdalud®). Instruktsia po primeneniju, protivopokazania i sostav. Entsiklopedia RLS® № PN012947/01 dated 03.08.2010 [on-line], [retrieved on 19.06.2014]. Found in Internet: <URL: http://www.rlsnet.ra/tn_index_id_2924.htm>, p. 1-7 * |
Also Published As
Publication number | Publication date |
---|---|
CN105209044A (zh) | 2015-12-30 |
EA201591603A1 (ru) | 2016-01-29 |
MY180772A (en) | 2020-12-09 |
CN105209044B (zh) | 2017-08-15 |
RU2509560C1 (ru) | 2014-03-20 |
UA112726C2 (uk) | 2016-10-10 |
HK1214156A1 (zh) | 2016-07-22 |
WO2014148951A1 (ru) | 2014-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mercadante et al. | Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study | |
JP4633262B2 (ja) | 心的外傷後ストレス障害、強迫性障害および関連する神経精神医学的障害の処置 | |
AU2002311784B8 (en) | Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning | |
EA006384B1 (ru) | Композиция фентанила для интраназального введения | |
JP2016537322A (ja) | Trpa1アンタゴニスト及び鎮痛剤を含む医薬組成物 | |
RU2509560C1 (ru) | Новые терапевтические комбинации миртазапина для применения при болевых расстройствах | |
JP2016074728A (ja) | 脱髄性および他の神経系疾患を患っている患者における神経認知的および/または神経精神医学的障害を改善するための4−アミノピリジンの使用 | |
JP6768520B2 (ja) | 医療用の(s)−ピルリンドールおよびその薬学的に許容可能な塩 | |
JP7264813B2 (ja) | 末梢神経障害性疼痛の治療に使用するための局所作用用フェニトイン | |
Khan et al. | Effect of gabapentin on opioid requirements in patients undergoing total abdominal hysterectomy | |
AU2016303610A1 (en) | Combination therapy using acamprosate and D-cycloserine | |
Keegan | Muscle relaxants and neuromuscular blockade | |
US20060084659A1 (en) | Augmentation of psychotherapy with cannabinoid reuptake inhibitors | |
Bufalari et al. | Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial | |
EP2138174A1 (en) | Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management | |
ES2649491T3 (es) | (R)-pirlindol y sus sales farmacéuticamente aceptables para uso en medicina | |
CZ20021116A3 (cs) | Synergické kombinace antagonisty receptoru NK1 a strukturálního analogu GABA | |
WO2005105120A2 (en) | Pharmaceutical combination, active on central nervous system (cns) and set of pharmaceuticals; method of treatment of cns-disorders; means facilitating penetration of the hematoencephalic barrier; pharmaceutical means for endonasal administration | |
Visser et al. | Salmon calcitonin in the treatment of post herpetic neuralgia | |
Chaudhary et al. | Rationalized approach for the treatment of neuropathic pain | |
DOURADO et al. | Treatment of chronic pain in dentistry using anticonvulsants | |
Saarma | Trazodone—a review of literature | |
WO2008010768A1 (en) | Method of treating and diagnosing restless legs syndrome and periodic limb movements during sleep and means for carrying out the method | |
BR112020016672A2 (pt) | Leucina, acetil-leucina ou um sal farmaceuticamente aceitável da mesma e método de reduzir, inibir ou eliminar um ou mais sintomas de síndrome das pernas inquietas (rls) em um indivíduo em necessidade do mesmo | |
BR112019022175A2 (pt) | Composições e método para tratamento de depressão |